Mmbg Investment Advisors CO. Takes Position in UnitedHealth Group Incorporated $UNH

Key Points

• Mmbg Investment Advisors initiated a UnitedHealth Group position by purchasing 10,928 shares worth approximately $4.54 million in the second quarter. Institutional investors collectively own 87.86% of the company.
• UnitedHealth reported quarterly EPS of $6.38, beating estimates of $4.94, while revenue reached $112.03 billion. The company issued FY 2026 EPS guidance of $19.50–$20.00 and maintains a quarterly dividend of $2.32 per share, yielding about 2.4%.
• Analysts remain broadly positive, with an average “Moderate Buy” rating and a consensus price target of $455.92. However, rising healthcare costs and efforts to prioritize Medicare Advantage profitability could pressure margins and slow membership growth.

Mmbg Investment Advisors CO. purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,928 shares of the healthcare conglomerate's stock, valued at approximately $4,542,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. West Family Investments Inc. acquired a new stake in UnitedHealth Group during the 2nd quarter valued at $1,288,000. SSI Investment Management LLC purchased a new position in UnitedHealth Group in the 2nd quarter valued at about $374,000. NewEdge Wealth LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth about $17,660,000. Dala Group LLC purchased a new position in UnitedHealth Group in the second quarter valued at about $1,629,000. Finally, Empirical Asset Management LLC acquired a new stake in UnitedHealth Group during the 2nd quarter valued at approximately $1,416,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 500 shares of the firm's stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total value of $205,000.00. Following the sale, the chief executive officer directly owned 16,497 shares in the company, valued at approximately $6,763,770. This trade represents a 2.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Up 1.6%

Shares of NYSE:UNH opened at $390.94 on Friday. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The company's fifty day moving average is $413.99 and its two-hundred day moving average is $355.96. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. The stock has a market capitalization of $350.91 billion, a price-to-earnings ratio of 25.16, a price-to-earnings-growth ratio of 1.34 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter in the prior year, the firm earned $4.08 EPS. The company's revenue for the quarter was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 19.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group's dividend payout ratio is presently 59.72%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on UNH shares. Erste Group Bank upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Monday, April 27th. Morgan Stanley upped their price target on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an "overweight" rating in a report on Friday, July 17th. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $466.00 to $516.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 21st. Oppenheimer increased their price target on shares of UnitedHealth Group from $420.00 to $500.00 and gave the stock an "outperform" rating in a research report on Friday, July 17th. Finally, HC Wainwright set a $492.00 price objective on UnitedHealth Group in a report on Wednesday, May 27th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average target price of $455.92.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is reportedly prioritizing Medicare Advantage profitability over rapid membership growth by tightening benefits, improving pricing and controlling costs. The strategy could support stronger margins and more sustainable earnings, even if enrollment growth moderates. Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?
• Positive Sentiment: Zacks Research added UNH to its Rank #1, or “Strong Buy,” lists for overall stocks, value stocks and income stocks. The repeated favorable rankings may reinforce investor confidence in the shares. New Strong Buy Stocks for August 21st
• Positive Sentiment: Analysts raised several forward EPS estimates, including Q1 2028 to $7.36 from $6.78 and Q2 2028 to $7.19 from $5.84. A separate report also noted an increase in the Q1 EPS estimate, while Zacks maintained a Strong Buy rating. Q1 EPS Estimate for UnitedHealth Group Increased by Analyst
• Neutral Sentiment: Forecast revisions were mixed: Q3 2027 EPS was reduced to $4.74 from $4.81 and Q4 2027 to $4.07 from $4.12, partially offsetting the increases for 2028.
• Negative Sentiment: Aon expects U.S. employer health-care costs to rise 9.5% in 2027. Persistent medical-cost inflation could pressure insurers’ margins and increase pricing, benefit and utilization-management challenges for UnitedHealth. AON Sees No Relief From Health-Cost Inflation

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source